US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

15.84

+0.16001.02%

Post-market: 15.840.00000.00%16:31 EDT

Volume:157.03K

Turnover:2.48M

Market Cap:844.23M

PE:-8.86

High:16.05

Open:15.57

Low:15.13

Close:15.68

52wk High:17.78

52wk Low:6.42

Shares:53.30M

Float Shares:17.22M

Volume Ratio:0.50

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7873

EPS(LYR):-1.5114

ROE:-31.21%

ROA:-21.29%

PB:2.79

PE(LYR):-10.48

Loading ...

Overview Company News Filings

Oppenheimer Adjusts Price Target on Tyra Bioscience to $36 From $30, Maintains Outperform Rating

MT Newswires Live

Tyra Biosciences Inc. : Oppenheimer Raises Target Price to $36 From $30

THOMSON REUTERS

Raymond James Initiates Tyra Bioscience at Strong Buy With $35 Price Target

MT Newswires Live

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Stock Track | Tyra Biosciences Soars 5.27% as Phase 2 Trial for Pediatric Achondroplasia Drug Begins

Tyra Biosciences Launches Phase 2 Trial for Dabogratinib, First FGFR3-Selective Inhibitor for Pediatric Achondroplasia

Tyra Biosciences Inc - Initial Results Expected in 2H 2026

THOMSON REUTERS

Tyra Biosciences Announces First Child Dosed in Beach301, Its Phase 2 Study for Dabogratinib (Tyra-300) in Pediatric Achondroplasia

THOMSON REUTERS

Tyra Biosciences Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference in New York

Tyra Biosciences Q2 EPS $(0.47) Beats $(0.53) Estimate

Tyra Biosciences Inc - Co Has $296.3 Mln Cash, Runway Through 2027 - SEC Filing

THOMSON REUTERS

Tyra Biosciences Q2 net loss widens to $28.1 mln

Tyra Biosciences Q2 Basic EPS USD -0.47 VS. Ibes Estimate USD -0.53

THOMSON REUTERS

Tyra Biosciences Q2 Operating Expenses USD 31.452 Million

THOMSON REUTERS

Tyra Biosciences Inc expected to post a loss of 53 cents a share - Earnings Preview

Tyra Biosciences to Participate in Virtual Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series

Tyra Biosciences Announces Promising Preclinical Results for TYRA-300 in FGFR3-related Skeletal Dysplasia at ENDO 2025

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Tyra Biosciences Initiates Phase 2 Trial of TYRA-300 for Bladder Cancer with First Patient Dosed

Director Gilla Kaplan Reports Disposal of Common Shares of Tyra Biosciences Inc

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TYRA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TYRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TYRA\",,,,,undefined,":{"symbol":"TYRA","market":"US","secType":"STK","nameCN":"Tyra Biosciences, Inc.","latestPrice":15.84,"timestamp":1761940800000,"preClose":15.68,"halted":0,"volume":157029,"hourTrading":{"tag":"盘后","latestPrice":15.84,"preClose":15.84,"latestTime":"16:31 EDT","volume":8715,"amount":138045.6,"timestamp":1761942691292},"delay":0,"floatShares":17219026,"shares":53297140,"eps":-1.78726,"marketStatus":"Post-Mkt","change":0.16,"latestTime":"10-31 16:56:31 EDT","open":15.57,"high":16.05,"low":15.13,"amount":2481432.557136,"amplitude":0.058673,"askPrice":18,"askSize":5,"bidPrice":14.67,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.78726,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1761955200000},"marketStatusCode":4,"adr":0,"listingDate":1631678400000,"exchange":"NASDAQ","adjPreClose":15.68,"preHourTrading":{"tag":"盘前","latestPrice":15.68,"preClose":15.68,"latestTime":"09:28 EDT","volume":1,"amount":15.68,"timestamp":1761917288173},"postHourTrading":{"tag":"盘后","latestPrice":15.84,"preClose":15.84,"latestTime":"16:31 EDT","volume":8715,"amount":138045.6,"timestamp":1761942691292},"volumeRatio":0.499013,"impliedVol":0.455,"impliedVolPercentile":0.42},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TYRA\",,,,,undefined,":{"symbol":"TYRA","floatShares":17219026,"roa":"-21.29%","roe":"-31.21%","lyrEps":-1.511436,"volumeRatio":0.499013,"shares":53297140,"dividePrice":0,"high":16.05,"amplitude":0.058673,"preClose":15.68,"low":15.13,"week52Low":6.42,"pbRate":"2.79","week52High":17.78,"institutionHeld":0,"latestPrice":15.84,"committee":0.95122,"eps":-1.78726,"divideRate":0,"volume":157029,"delay":0,"ttmEps":-1.78726,"open":15.57,"prevYearClose":13.9,"prevWeekClose":14.23,"prevMonthClose":13.99,"prevQuarterClose":13.99,"fiveDayClose":14.23,"twentyDayClose":13.66,"sixtyDayClose":10.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TYRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"TYRA","fiscalQuarterEnding":"2025/06","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-05-08","symbol":"TYRA","fiscalQuarterEnding":"2025/03","expectedEps":-0.49,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-0.47},{"market":"US","date":"2025-03-27","symbol":"TYRA","fiscalQuarterEnding":"2024/12","expectedEps":-0.48,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2024-11-07","symbol":"TYRA","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2024-08-07","symbol":"TYRA","fiscalQuarterEnding":"2024/06","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TYRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TYRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5556,"buy":0.4444,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5556,"analysts":9,"updateTime":1756872000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TYRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TYRA","date":"2025-10-30","current":-8.773206,"percent":0.71499,"low":-65.065957,"twenty":-14.29384,"median":-10.607566,"eighty":-6.446171,"high":-2.262019,"avg":-13.22254,"sd":10.46017,"marketCap":812248413},"quantilePoints":[{"date":"2021-09-17","current":-51.874044,"twenty":-54.675424,"median":-51.874044,"eighty":-7.368402,"marketCap":816756820},{"date":"2021-09-24","current":-45.881563,"twenty":-51.914793,"median":-48.148284,"eighty":-38.43425,"marketCap":722405203},{"date":"2021-10-01","current":-44.735175,"twenty":-51.686453,"median":-46.767408,"eighty":-44.599693,"marketCap":704355329},{"date":"2021-10-08","current":-42.364237,"twenty":-48.992442,"median":-45.855508,"eighty":-37.903746,"marketCap":667024906},{"date":"2021-10-15","current":-42.572671,"twenty":-48.038856,"median":-44.057764,"eighty":-39.159562,"marketCap":670306702},{"date":"2021-10-22","current":-59.872704,"twenty":-51.686453,"median":-45.855508,"eighty":-39.967244,"marketCap":942695717},{"date":"2021-10-29","current":-58.335502,"twenty":-54.750435,"median":-46.767408,"eighty":-40.665499,"marketCap":918492476},{"date":"2021-11-05","current":-57.556958,"twenty":-58.377189,"median":-47.731415,"eighty":-42.051586,"marketCap":1153959443},{"date":"2021-11-12","current":-55.894516,"twenty":-58.377189,"median":-48.565152,"eighty":-42.38508,"marketCap":1120629160},{"date":"2021-11-19","current":-48.656815,"twenty":-57.712667,"median":-50.148185,"eighty":-42.536195,"marketCap":975520488},{"date":"2021-11-26","current":-48.393257,"twenty":-57.532629,"median":-48.479204,"eighty":-42.379869,"marketCap":970236418},{"date":"2021-12-03","current":-35.945222,"twenty":-57.333947,"median":-48.393257,"eighty":-41.807779,"marketCap":720665760},{"date":"2021-12-10","current":-35.742485,"twenty":-57.175812,"median":-48.139033,"eighty":-39.810919,"marketCap":716601091},{"date":"2021-12-17","current":-25.362365,"twenty":-56.604095,"median":-46.949787,"eighty":-37.687508,"marketCap":508490054},{"date":"2021-12-23","current":-30.065857,"twenty":-56.125636,"median":-46.386164,"eighty":-35.857226,"marketCap":602790368},{"date":"2021-12-31","current":-28.525058,"twenty":-55.948606,"median":-45.855508,"eighty":-33.556984,"marketCap":571898886},{"date":"2022-01-07","current":-24.429776,"twenty":-55.920912,"median":-44.057764,"eighty":-29.676603,"marketCap":489792578},{"date":"2022-01-14","current":-25.260997,"twenty":-55.661992,"median":-42.573692,"eighty":-28.354759,"marketCap":506457720},{"date":"2022-01-21","current":-23.416092,"twenty":-55.172514,"median":-42.377264,"eighty":-27.774932,"marketCap":469469234},{"date":"2022-01-28","current":-24.733881,"twenty":-54.550428,"median":-40.800981,"eighty":-25.21234,"marketCap":495889581},{"date":"2022-02-04","current":-27.105901,"twenty":-53.98167,"median":-39.732756,"eighty":-25.21234,"marketCap":543446205},{"date":"2022-02-11","current":-24.855523,"twenty":-52.540096,"median":-38.702442,"eighty":-25.005548,"marketCap":498328382},{"date":"2022-02-18","current":-22.848429,"twenty":-52.037042,"median":-36.523022,"eighty":-24.806866,"marketCap":458088162},{"date":"2022-02-25","current":-24.308134,"twenty":-51.874044,"median":-35.871892,"eighty":-24.733881,"marketCap":487353777},{"date":"2022-03-04","current":-16.525662,"twenty":-51.639555,"median":-35.069042,"eighty":-24.470323,"marketCap":434525766},{"date":"2022-03-11","current":-17.182311,"twenty":-50.866646,"median":-31.799256,"eighty":-24.348681,"marketCap":451791690},{"date":"2022-03-18","current":-19.887079,"twenty":-50.643635,"median":-30.065857,"eighty":-24.06485,"marketCap":522910855},{"date":"2022-03-25","current":-18.073477,"twenty":-48.656815,"median":-28.707521,"eighty":-23.618829,"marketCap":475224016},{"date":"2022-04-01","current":-17.495001,"twenty":-48.565152,"median":-28.241226,"eighty":-23.213356,"marketCap":460013559},{"date":"2022-04-08","current":-14.915309,"twenty":-48.393257,"median":-27.805343,"eighty":-22.524051,"marketCap":392183141},{"date":"2022-04-14","current":-15.446882,"twenty":-48.343183,"median":-27.278227,"eighty":-18.892725,"marketCap":406160318},{"date":"2022-04-22","current":-13.211149,"twenty":-48.315863,"median":-26.578785,"eighty":-18.298614,"marketCap":347373956},{"date":"2022-04-29","current":-12.091947,"twenty":-48.035156,"median":-25.727291,"eighty":-17.491874,"marketCap":317945647},{"date":"2022-05-06","current":-10.035699,"twenty":-47.590722,"median":-25.484007,"eighty":-17.232341,"marketCap":370427692},{"date":"2022-05-13","current":-8.678918,"twenty":-47.059215,"median":-25.230587,"eighty":-16.716403,"marketCap":320347524},{"date":"2022-05-20","current":-10.607566,"twenty":-46.803884,"median":-24.956891,"eighty":-16.381825,"marketCap":391535862},{"date":"2022-05-27","current":-8.880753,"twenty":-46.462413,"median":-24.794702,"eighty":-15.365583,"marketCap":327797466},{"date":"2022-06-03","current":-8.241608,"twenty":-46.349157,"median":-24.754154,"eighty":-14.840263,"marketCap":304205982},{"date":"2022-06-10","current":-6.615712,"twenty":-46.058732,"median":-24.693334,"eighty":-14.03432,"marketCap":244192557},{"date":"2022-06-17","current":-5.898076,"twenty":-45.850298,"median":-24.470323,"eighty":-13.117342,"marketCap":217703872},{"date":"2022-06-24","current":-8.017346,"twenty":-45.391742,"median":-24.429776,"eighty":-12.264461,"marketCap":295928268},{"date":"2022-07-01","current":-9.396554,"twenty":-44.464211,"median":-24.308134,"eighty":-10.298085,"marketCap":346836208},{"date":"2022-07-08","current":-11.784938,"twenty":-43.781589,"median":-24.125671,"eighty":-10.120919,"marketCap":434993860},{"date":"2022-07-15","current":-10.820614,"twenty":-42.656453,"median":-24.034439,"eighty":-10.31154,"marketCap":399399690},{"date":"2022-07-22","current":-10.226321,"twenty":-42.574305,"median":-23.618829,"eighty":-10.239777,"marketCap":377463749},{"date":"2022-07-29","current":-11.941921,"twenty":-42.536195,"median":-23.365408,"eighty":-10.264446,"marketCap":440788259},{"date":"2022-08-05","current":-9.27865,"twenty":-42.38508,"median":-23.010619,"eighty":-10.239777,"marketCap":431401571},{"date":"2022-08-12","current":-11.112906,"twenty":-42.086008,"median":-22.524051,"eighty":-10.046912,"marketCap":516683463},{"date":"2022-08-19","current":-9.314441,"twenty":-40.938671,"median":-18.902106,"eighty":-9.931125,"marketCap":433065608},{"date":"2022-08-26","current":-6.952277,"twenty":-40.742145,"median":-18.714492,"eighty":-9.684871,"marketCap":323239171},{"date":"2022-09-02","current":-6.343841,"twenty":-40.430153,"median":-18.354898,"eighty":-9.439164,"marketCap":294950544},{"date":"2022-09-09","current":-7.283338,"twenty":-40.12357,"median":-17.69825,"eighty":-9.329276,"marketCap":338631513},{"date":"2022-09-16","current":-6.925434,"twenty":-39.341942,"median":-17.487184,"eighty":-9.183506,"marketCap":321991144},{"date":"2022-09-23","current":-6.549636,"twenty":-39.209284,"median":-17.276118,"eighty":-8.936818,"marketCap":304518756},{"date":"2022-09-30","current":-7.864931,"twenty":-38.702442,"median":-17.158859,"eighty":-8.644998,"marketCap":365672113},{"date":"2022-10-07","current":-5.592243,"twenty":-38.430042,"median":-16.728911,"eighty":-8.330206,"marketCap":260005768},{"date":"2022-10-14","current":-6.021728,"twenty":-36.573706,"median":-16.517845,"eighty":-8.107051,"marketCap":279974211},{"date":"2022-10-21","current":-6.173837,"twenty":-36.472338,"median":-16.119165,"eighty":-8.017346,"marketCap":287046368},{"date":"2022-10-28","current":-6.308051,"twenty":-35.945222,"median":-15.485969,"eighty":-7.855984,"marketCap":293286507},{"date":"2022-11-04","current":-5.192146,"twenty":-35.798562,"median":-14.962213,"eighty":-7.658528,"marketCap":271860751},{"date":"2022-11-11","current":-6.446249,"twenty":-35.742485,"median":-14.599591,"eighty":-7.283338,"marketCap":337525579},{"date":"2022-11-18","current":-5.695384,"twenty":-35.069042,"median":-14.196122,"eighty":-7.030596,"marketCap":298210332},{"date":"2022-11-25","current":-5.391844,"twenty":-35.007696,"median":-13.66455,"eighty":-6.932592,"marketCap":282316934},{"date":"2022-12-02","current":-5.415807,"twenty":-33.078525,"median":-13.093891,"eighty":-6.735745,"marketCap":283571676},{"date":"2022-12-09","current":-5.272025,"twenty":-31.31877,"median":-12.523231,"eighty":-6.611227,"marketCap":276043224},{"date":"2022-12-16","current":-5.599529,"twenty":-30.609192,"median":-12.013693,"eighty":-6.540688,"marketCap":293191364},{"date":"2022-12-23","current":-7.037354,"twenty":-30.155061,"median":-11.829791,"eighty":-6.504003,"marketCap":368475880},{"date":"2022-12-30","current":-6.070817,"twenty":-29.676603,"median":-11.527038,"eighty":-6.4333,"marketCap":317867955},{"date":"2023-01-06","current":-5.471723,"twenty":-29.190035,"median":-11.493015,"eighty":-6.361736,"marketCap":286499407},{"date":"2023-01-13","current":-6.701862,"twenty":-28.735904,"median":-11.067302,"eighty":-6.324156,"marketCap":350909493},{"date":"2023-01-20","current":-6.342406,"twenty":-28.557496,"median":-10.925592,"eighty":-6.320577,"marketCap":332088364},{"date":"2023-01-27","current":-6.853632,"twenty":-28.468292,"median":-10.798188,"eighty":-6.311763,"marketCap":358856191},{"date":"2023-02-03","current":-10.528074,"twenty":-28.180405,"median":-10.632567,"eighty":-6.320577,"marketCap":551249954},{"date":"2023-02-10","current":-10.863566,"twenty":-27.920902,"median":-10.69237,"eighty":-6.336396,"marketCap":568816341},{"date":"2023-02-17","current":-10.464171,"twenty":-27.835753,"median":-10.666787,"eighty":-6.342406,"marketCap":547903976},{"date":"2023-02-24","current":-8.403288,"twenty":-27.754658,"median":-10.615748,"eighty":-6.342406,"marketCap":439996170},{"date":"2023-03-03","current":-9.689343,"twenty":-27.450553,"median":-10.552038,"eighty":-6.343841,"marketCap":507333987},{"date":"2023-03-10","current":-9.649403,"twenty":-27.105901,"median":-10.607566,"eighty":-6.388579,"marketCap":505242750},{"date":"2023-03-17","current":-12.213524,"twenty":-26.923438,"median":-10.623929,"eighty":-6.406474,"marketCap":639500136},{"date":"2023-03-24","current":-12.233106,"twenty":-26.578785,"median":-10.714065,"eighty":-6.413877,"marketCap":676796572},{"date":"2023-03-31","current":-12.325142,"twenty":-25.88948,"median":-10.798188,"eighty":-6.446249,"marketCap":681888459},{"date":"2023-04-06","current":-11.941659,"twenty":-25.759729,"median":-10.820614,"eighty":-6.47181,"marketCap":660672265},{"date":"2023-04-14","current":-11.880301,"twenty":-25.727291,"median":-10.86297,"eighty":-6.495979,"marketCap":657277674},{"date":"2023-04-21","current":-11.812765,"twenty":-25.548883,"median":-10.871554,"eighty":-6.504003,"marketCap":653541246},{"date":"2023-04-28","current":-10.629943,"twenty":-25.488062,"median":-10.863566,"eighty":-6.540688,"marketCap":588101580},{"date":"2023-05-05","current":-9.880049,"twenty":-25.386693,"median":-10.863566,"eighty":-6.578268,"marketCap":546613686},{"date":"2023-05-12","current":-9.977645,"twenty":-25.281271,"median":-10.86297,"eighty":-6.585426,"marketCap":522619092},{"date":"2023-05-19","current":-10.782032,"twenty":-25.21234,"median":-10.807651,"eighty":-6.591714,"marketCap":564752064},{"date":"2023-05-26","current":-10.562654,"twenty":-25.200176,"median":-10.814132,"eighty":-6.611227,"marketCap":553261254},{"date":"2023-06-02","current":-11.180163,"twenty":-25.054205,"median":-10.86297,"eighty":-6.624267,"marketCap":585605758},{"date":"2023-06-09","current":-11.793609,"twenty":-24.89607,"median":-10.871554,"eighty":-6.639557,"marketCap":617737469},{"date":"2023-06-16","current":-13.00019,"twenty":-24.81903,"median":-10.958505,"eighty":-6.657951,"marketCap":680936928},{"date":"2023-06-23","current":-13.227693,"twenty":-24.794702,"median":-10.97886,"eighty":-6.673112,"marketCap":692853324},{"date":"2023-06-30","current":-13.430821,"twenty":-24.790647,"median":-11.067302,"eighty":-6.687452,"marketCap":703492963},{"date":"2023-07-07","current":-12.008925,"twenty":-24.774428,"median":-11.109286,"eighty":-6.701862,"marketCap":629015487},{"date":"2023-07-14","current":-12.545183,"twenty":-24.733881,"median":-11.132449,"eighty":-6.728587,"marketCap":657104135},{"date":"2023-07-21","current":-12.374555,"twenty":-24.693334,"median":-11.194382,"eighty":-6.737535,"marketCap":648166838},{"date":"2023-07-28","current":-10.684531,"twenty":-24.693334,"median":-11.215035,"eighty":-6.789729,"marketCap":559645037},{"date":"2023-08-04","current":-12.025175,"twenty":-24.612239,"median":-11.319809,"eighty":-6.789729,"marketCap":629866658},{"date":"2023-08-11","current":-12.854129,"twenty":-24.470323,"median":-11.375166,"eighty":-6.818063,"marketCap":649853327},{"date":"2023-08-18","current":-12.088496,"twenty":-24.470323,"median":-11.490542,"eighty":-6.839974,"marketCap":611145982},{"date":"2023-08-25","current":-12.718016,"twenty":-24.429776,"median":-11.503531,"eighty":-6.845644,"marketCap":642972021},{"date":"2023-09-01","current":-12.956213,"twenty":-24.429776,"median":-11.606732,"eighty":-6.853632,"marketCap":655014307},{"date":"2023-09-08","current":-12.905171,"twenty":-24.3649,"median":-11.635021,"eighty":-6.911074,"marketCap":652433817},{"date":"2023-09-15","current":-12.64996,"twenty":-24.316243,"median":-11.700171,"eighty":-6.925506,"marketCap":639531368},{"date":"2023-09-22","current":-11.773735,"twenty":-24.243258,"median":-11.748921,"eighty":-6.93261,"marketCap":595232962},{"date":"2023-09-29","current":-11.612102,"twenty":-24.145945,"median":-11.757046,"eighty":-6.934382,"marketCap":587061411},{"date":"2023-10-06","current":-12.343707,"twenty":-24.077014,"median":-11.765172,"eighty":-6.948698,"marketCap":624048430},{"date":"2023-10-13","current":-11.994918,"twenty":-24.048631,"median":-11.773735,"eighty":-7.001168,"marketCap":606415084},{"date":"2023-10-20","current":-12.156552,"twenty":-24.028357,"median":-11.792179,"eighty":-7.027155,"marketCap":614586634},{"date":"2023-10-27","current":-9.366245,"twenty":-24.008083,"median":-11.792179,"eighty":-7.030596,"marketCap":473519863},{"date":"2023-11-03","current":-10.846469,"twenty":-23.878332,"median":-11.773735,"eighty":-7.031038,"marketCap":548354065},{"date":"2023-11-10","current":-8.466057,"twenty":-23.582336,"median":-11.765172,"eighty":-7.033715,"marketCap":501182106},{"date":"2023-11-17","current":-8.546063,"twenty":-23.432311,"median":-11.727726,"eighty":-7.044973,"marketCap":505918363},{"date":"2023-11-24","current":-8.131488,"twenty":-23.416092,"median":-11.700171,"eighty":-7.075448,"marketCap":481375940},{"date":"2023-12-01","current":-8.51697,"twenty":-23.314724,"median":-11.635021,"eighty":-7.283338,"marketCap":504196088},{"date":"2023-12-08","current":-9.542497,"twenty":-23.213356,"median":-11.612102,"eighty":-7.355775,"marketCap":564906291},{"date":"2023-12-15","current":-10.749856,"twenty":-23.010619,"median":-11.539795,"eighty":-7.471237,"marketCap":636380715},{"date":"2023-12-22","current":-9.949799,"twenty":-22.848429,"median":-11.493398,"eighty":-7.636102,"marketCap":589018145},{"date":"2023-12-29","current":-10.10981,"twenty":-22.653802,"median":-11.490542,"eighty":-7.649558,"marketCap":598490659},{"date":"2024-01-05","current":-8.836992,"twenty":-22.524051,"median":-11.450468,"eighty":-7.658528,"marketCap":523141116},{"date":"2024-01-12","current":-9.520677,"twenty":-21.996657,"median":-11.362997,"eighty":-7.671984,"marketCap":563614585},{"date":"2024-01-19","current":-9.273387,"twenty":-19.887079,"median":-11.319809,"eighty":-7.725806,"marketCap":548975245},{"date":"2024-01-26","current":-9.709782,"twenty":-18.902106,"median":-11.215035,"eighty":-7.826724,"marketCap":574809374},{"date":"2024-02-02","current":-9.462491,"twenty":-18.902106,"median":-11.176101,"eighty":-7.855984,"marketCap":560170034},{"date":"2024-02-09","current":-16.14523,"twenty":-18.855202,"median":-11.215035,"eighty":-7.864931,"marketCap":955781445},{"date":"2024-02-16","current":-16.799527,"twenty":-18.573781,"median":-11.319809,"eighty":-7.963355,"marketCap":994515195},{"date":"2024-02-23","current":-16.684583,"twenty":-18.486228,"median":-11.362997,"eighty":-8.006548,"marketCap":987710617},{"date":"2024-03-01","current":-17.674871,"twenty":-18.376786,"median":-11.450468,"eighty":-8.017346,"marketCap":1046334670},{"date":"2024-03-08","current":-17.24162,"twenty":-18.129761,"median":-11.493206,"eighty":-8.033018,"marketCap":1020686647},{"date":"2024-03-15","current":-15.694295,"twenty":-17.773295,"median":-11.527038,"eighty":-8.042754,"marketCap":929086563},{"date":"2024-03-22","current":-12.709769,"twenty":-17.68662,"median":-11.59926,"eighty":-8.051107,"marketCap":878677166},{"date":"2024-03-28","current":-12.383098,"twenty":-17.678408,"median":-11.630959,"eighty":-8.058199,"marketCap":856093115},{"date":"2024-04-05","current":-13.674587,"twenty":-17.64304,"median":-11.659545,"eighty":-8.067147,"marketCap":945378900},{"date":"2024-04-12","current":-11.449278,"twenty":-17.605904,"median":-11.679858,"eighty":-8.092521,"marketCap":791534419},{"date":"2024-04-19","current":-11.137785,"twenty":-17.572641,"median":-11.63517,"eighty":-8.121713,"marketCap":769999641},{"date":"2024-04-26","current":-11.479668,"twenty":-17.520016,"median":-11.644789,"eighty":-8.131488,"marketCap":793635373},{"date":"2024-05-03","current":-14.077978,"twenty":-17.485621,"median":-11.700171,"eighty":-8.143737,"marketCap":973266940},{"date":"2024-05-10","current":-12.364122,"twenty":-17.453431,"median":-11.734261,"eighty":-8.152745,"marketCap":932823576},{"date":"2024-05-17","current":-13.30104,"twenty":-17.409615,"median":-11.773297,"eighty":-8.178684,"marketCap":1003510256},{"date":"2024-05-24","current":-11.838622,"twenty":-17.391931,"median":-11.774851,"eighty":-8.195836,"marketCap":893176668},{"date":"2024-05-31","current":-10.968135,"twenty":-17.370621,"median":-11.773735,"eighty":-8.196374,"marketCap":827501913},{"date":"2024-06-07","current":-13.784326,"twenty":-17.313641,"median":-11.773735,"eighty":-8.202765,"marketCap":1039972230},{"date":"2024-06-14","current":-13.819135,"twenty":-17.269864,"median":-11.784938,"eighty":-8.217516,"marketCap":1042598422},{"date":"2024-06-21","current":-11.828065,"twenty":-17.244849,"median":-11.793609,"eighty":-8.241608,"marketCap":892380211},{"date":"2024-06-28","current":-10.755951,"twenty":-17.243557,"median":-11.793609,"eighty":-8.264474,"marketCap":811493482},{"date":"2024-07-05","current":-11.814142,"twenty":-17.24162,"median":-11.798153,"eighty":-8.305059,"marketCap":891329734},{"date":"2024-07-12","current":-13.220421,"twenty":-17.229758,"median":-11.813454,"eighty":-8.344822,"marketCap":997427911},{"date":"2024-07-15","current":-13.791287,"twenty":-17.217896,"median":-11.814142,"eighty":-8.359439,"marketCap":1040497468},{"date":"2024-08-02","current":-14.97479,"twenty":-17.206035,"median":-11.814142,"eighty":-8.374055,"marketCap":1129788013},{"date":"2024-08-09","current":-13.171002,"twenty":-17.17015,"median":-11.81627,"eighty":-8.427857,"marketCap":1072659555},{"date":"2024-08-16","current":-14.245921,"twenty":-17.156738,"median":-11.834207,"eighty":-8.444237,"marketCap":1160202076},{"date":"2024-08-23","current":-14.096987,"twenty":-17.142591,"median":-11.862673,"eighty":-8.457329,"marketCap":1148072690},{"date":"2024-08-30","current":-14.330102,"twenty":-17.135452,"median":-11.879612,"eighty":-8.476323,"marketCap":1167057815},{"date":"2024-09-06","current":-13.663134,"twenty":-17.131915,"median":-11.904884,"eighty":-8.490869,"marketCap":1112739263},{"date":"2024-09-13","current":-13.306986,"twenty":-17.091308,"median":-11.941659,"eighty":-8.508242,"marketCap":1083734211},{"date":"2024-09-20","current":-15.53453,"twenty":-17.038257,"median":-11.947152,"eighty":-8.522788,"marketCap":1265147627},{"date":"2024-09-27","current":-15.15248,"twenty":-17.02411,"median":-11.981875,"eighty":-8.532169,"marketCap":1234033117},{"date":"2024-10-04","current":-13.973954,"twenty":-16.921545,"median":-12.001921,"eighty":-8.538314,"marketCap":1138052763},{"date":"2024-10-11","current":-13.585429,"twenty":-16.799527,"median":-12.018355,"eighty":-8.548972,"marketCap":1106410888},{"date":"2024-10-18","current":-16.823138,"twenty":-16.799527,"median":-12.027061,"eighty":-8.572172,"marketCap":1370093178},{"date":"2024-10-25","current":-18.550651,"twenty":-17.038257,"median":-12.029957,"eighty":-8.604911,"marketCap":1510783579},{"date":"2024-10-31","current":-10.354907,"twenty":-17.031184,"median":-12.029957,"eighty":-8.618311,"marketCap":843314007},{"date":"2024-11-08","current":-10.994734,"twenty":-16.96694,"median":-12.027061,"eighty":-8.649539,"marketCap":905625249},{"date":"2024-11-15","current":-10.316762,"twenty":-16.818416,"median":-12.018355,"eighty":-8.669947,"marketCap":863925620},{"date":"2024-11-22","current":-9.698009,"twenty":-16.799527,"median":-12.001921,"eighty":-8.687259,"marketCap":812111232},{"date":"2024-11-29","current":-9.90005,"twenty":-16.799527,"median":-11.987275,"eighty":-8.720621,"marketCap":829030216},{"date":"2024-12-06","current":-9.578046,"twenty":-16.775814,"median":-11.952383,"eighty":-8.727894,"marketCap":802065585},{"date":"2024-12-13","current":-9.578046,"twenty":-16.771335,"median":-11.941659,"eighty":-8.836992,"marketCap":802065585},{"date":"2024-12-20","current":-9.155021,"twenty":-16.728911,"median":-11.905122,"eighty":-8.844266,"marketCap":766641462},{"date":"2024-12-27","current":-9.234147,"twenty":-16.721742,"median":-11.880301,"eighty":-8.842811,"marketCap":773267451},{"date":"2025-01-03","current":-9.06454,"twenty":-16.69873,"median":-11.874643,"eighty":-8.819966,"marketCap":759064580},{"date":"2025-01-10","current":-10.031927,"twenty":-16.677299,"median":-11.849623,"eighty":-8.837554,"marketCap":840073551},{"date":"2025-01-17","current":-10.144998,"twenty":-16.65951,"median":-11.828928,"eighty":-8.840745,"marketCap":849542132},{"date":"2025-01-24","current":-10.201534,"twenty":-16.6333,"median":-11.81627,"eighty":-8.845605,"marketCap":854276422},{"date":"2025-01-31","current":-9.240429,"twenty":-16.560844,"median":-11.814142,"eighty":-8.850961,"marketCap":773793483},{"date":"2025-02-07","current":-8.273042,"twenty":-16.522535,"median":-11.801975,"eighty":-8.837273,"marketCap":692784512},{"date":"2025-02-14","current":-7.695122,"twenty":-16.49752,"median":-11.790749,"eighty":-8.728637,"marketCap":644389543},{"date":"2025-02-21","current":-8.028054,"twenty":-16.44749,"median":-11.775967,"eighty":-8.678918,"marketCap":672269253},{"date":"2025-02-28","current":-7.36219,"twenty":-16.286699,"median":-11.773516,"eighty":-8.600426,"marketCap":616509832},{"date":"2025-03-07","current":-6.947596,"twenty":-16.14523,"median":-11.740796,"eighty":-8.546063,"marketCap":581791701},{"date":"2025-03-14","current":-6.746581,"twenty":-16.119165,"median":-11.707178,"eighty":-8.502423,"marketCap":564958668},{"date":"2025-03-21","current":-6.872215,"twenty":-15.915341,"median":-11.654408,"eighty":-8.444237,"marketCap":575479314},{"date":"2025-03-28","current":-5.930193,"twenty":-15.838874,"median":-11.630959,"eighty":-8.285605,"marketCap":512848984},{"date":"2025-04-04","current":-5.0953,"twenty":-15.77412,"median":-11.586419,"eighty":-8.211493,"marketCap":440646643},{"date":"2025-04-11","current":-4.634881,"twenty":-15.694295,"median":-11.515284,"eighty":-8.153307,"marketCap":400829175},{"date":"2025-04-17","current":-5.285606,"twenty":-15.683979,"median":-11.493206,"eighty":-8.126601,"marketCap":457104529},{"date":"2025-04-25","current":-6.194166,"twenty":-15.563904,"median":-11.479668,"eighty":-8.053111,"marketCap":535677666},{"date":"2025-05-02","current":-6.433584,"twenty":-15.52695,"median":-11.445479,"eighty":-8.03308,"marketCap":556382749},{"date":"2025-05-09","current":-5.55293,"twenty":-15.483609,"median":-11.380902,"eighty":-7.962475,"marketCap":535502359},{"date":"2025-05-16","current":-5.437129,"twenty":-15.452155,"median":-11.342685,"eighty":-7.850132,"marketCap":524334981},{"date":"2025-05-23","current":-5.288242,"twenty":-15.351229,"median":-11.305077,"eighty":-7.68884,"marketCap":509976924},{"date":"2025-05-30","current":-5.100755,"twenty":-15.31566,"median":-11.236314,"eighty":-7.649558,"marketCap":491896407},{"date":"2025-06-06","current":-5.608073,"twenty":-15.257382,"median":-11.211818,"eighty":-7.522649,"marketCap":540820158},{"date":"2025-06-13","current":-5.696303,"twenty":-15.180972,"median":-11.180163,"eighty":-7.3268,"marketCap":549328636},{"date":"2025-06-20","current":-5.238613,"twenty":-15.136939,"median":-11.141584,"eighty":-7.055272,"marketCap":505190905},{"date":"2025-06-27","current":-5.420586,"twenty":-15.098086,"median":-11.134078,"eighty":-7.030596,"marketCap":522739641},{"date":"2025-07-03","current":-5.51433,"twenty":-15.067897,"median":-11.123525,"eighty":-6.980261,"marketCap":531779900},{"date":"2025-07-11","current":-5.646674,"twenty":-15.036902,"median":-11.105666,"eighty":-6.934382,"marketCap":544542617},{"date":"2025-07-18","current":-5.988562,"twenty":-15.013336,"median":-11.095088,"eighty":-6.873471,"marketCap":577512971},{"date":"2025-07-25","current":-5.944447,"twenty":-14.972275,"median":-10.994734,"eighty":-6.841108,"marketCap":573258732},{"date":"2025-08-01","current":-6.027162,"twenty":-14.952832,"median":-10.973575,"eighty":-6.801081,"marketCap":581235430},{"date":"2025-08-08","current":-5.927904,"twenty":-14.890218,"median":-10.964401,"eighty":-6.746581,"marketCap":571663392},{"date":"2025-08-15","current":-5.388535,"twenty":-14.779495,"median":-10.953036,"eighty":-6.704524,"marketCap":570279398},{"date":"2025-08-22","current":-5.892136,"twenty":-14.735981,"median":-10.871554,"eighty":-6.666136,"marketCap":623576538},{"date":"2025-08-29","current":-6.229549,"twenty":-14.719406,"median":-10.863566,"eighty":-6.597771,"marketCap":659285621},{"date":"2025-09-05","current":-6.113721,"twenty":-14.68625,"median":-10.854422,"eighty":-6.549636,"marketCap":647027279},{"date":"2025-09-12","current":-6.279909,"twenty":-14.491987,"median":-10.807651,"eighty":-6.4782,"marketCap":664615335},{"date":"2025-09-19","current":-6.441061,"twenty":-14.479036,"median":-10.768991,"eighty":-6.441061,"marketCap":681670420},{"date":"2025-09-26","current":-6.315161,"twenty":-14.471486,"median":-10.743748,"eighty":-6.425953,"marketCap":668346135},{"date":"2025-10-03","current":-6.743222,"twenty":-14.461909,"median":-10.700638,"eighty":-6.432494,"marketCap":713648704},{"date":"2025-10-10","current":-6.959771,"twenty":-14.440184,"median":-10.646686,"eighty":-6.433584,"marketCap":736566474},{"date":"2025-10-17","current":-7.473444,"twenty":-14.350333,"median":-10.635574,"eighty":-6.441061,"marketCap":790929557},{"date":"2025-10-24","current":-7.110851,"twenty":-14.330102,"median":-10.623929,"eighty":-6.445861,"marketCap":752555616},{"date":"2025-10-30","current":-7.674885,"twenty":-14.29384,"median":-10.607566,"eighty":-6.446171,"marketCap":812248413}],"updateTime":1761917206936},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TYRA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2566601951","title":"Oppenheimer Adjusts Price Target on Tyra Bioscience to $36 From $30, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2566601951","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566601951?lang=en_us&edition=fundamental","pubTime":"2025-09-10 21:05","pubTimestamp":1757509549,"startTime":"0","endTime":"0","summary":"Tyra Bioscience (TYRA) has an average rating of buy and mean price target of $31.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","TYRA"],"gpt_icon":0},{"id":"2566606663","title":"Tyra Biosciences Inc. : Oppenheimer Raises Target Price to $36 From $30","url":"https://stock-news.laohu8.com/highlight/detail?id=2566606663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566606663?lang=en_us&edition=fundamental","pubTime":"2025-09-10 20:20","pubTimestamp":1757506815,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250910:nAZN4HVZJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2564360148","title":"Raymond James Initiates Tyra Bioscience at Strong Buy With $35 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2564360148","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564360148?lang=en_us&edition=fundamental","pubTime":"2025-09-03 19:27","pubTimestamp":1756898820,"startTime":"0","endTime":"0","summary":"Tyra Bioscience, Inc (TYRA) has an average rating of buy and mean price target of $30.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RJF","TYRA"],"gpt_icon":0},{"id":"2561343476","title":"Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2561343476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561343476?lang=en_us&edition=fundamental","pubTime":"2025-08-22 19:08","pubTimestamp":1755860880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TYRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 22, 2025 07:08 ET (11:08 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA"],"gpt_icon":0},{"id":"1185651858","title":"Stock Track | Tyra Biosciences Soars 5.27% as Phase 2 Trial for Pediatric Achondroplasia Drug Begins","url":"https://stock-news.laohu8.com/highlight/detail?id=1185651858","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185651858?lang=en_us&edition=fundamental","pubTime":"2025-08-21 22:20","pubTimestamp":1755786041,"startTime":"0","endTime":"0","summary":"Shares of Tyra Biosciences, Inc. (TYRA) are soaring 5.27% in Thursday's trading session following the announcement that the company has dosed the first child in its Phase 2 clinical study for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["TYRA"],"gpt_icon":0},{"id":"2561467558","title":"Tyra Biosciences Launches Phase 2 Trial for Dabogratinib, First FGFR3-Selective Inhibitor for Pediatric Achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2561467558","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561467558?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:01","pubTimestamp":1755777677,"startTime":"0","endTime":"0","summary":"Tyra Biosciences Inc. has announced the initiation of BEACH301, a Phase 2 clinical study focused on evaluating the safety and efficacy of dabogratinib in children with achondroplasia, the most common form of dwarfism. Dabogratinib is a potentially first-in-class, once-daily oral FGFR3-selective inhibitor, developed using Tyra's SNP platform. As of now, the first child has been dosed in the study. Initial results from the safety sentinel cohort of the trial are anticipated to be available in the second half of 2026. Tyra Biosciences emphasizes that dabogratinib is the only oral FGFR3-selective inhibitor currently in clinical development for achondroplasia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDLb4gf2S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2561446203","title":"Tyra Biosciences Inc - Initial Results Expected in 2H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2561446203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561446203?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:00","pubTimestamp":1755777605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA1L5TH7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2561013462","title":"Tyra Biosciences Announces First Child Dosed in Beach301, Its Phase 2 Study for Dabogratinib (Tyra-300) in Pediatric Achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2561013462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561013462?lang=en_us&edition=fundamental","pubTime":"2025-08-21 20:00","pubTimestamp":1755777605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nTUA1L5TH7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2561489250","title":"Tyra Biosciences Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference in New York","url":"https://stock-news.laohu8.com/highlight/detail?id=2561489250","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561489250?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:06","pubTimestamp":1755720395,"startTime":"0","endTime":"0","summary":"Tyra Biosciences Inc., a clinical-stage biotechnology company, will participate in the H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10, 2025, at 9 AM ET in New York, NY. The event will feature a fireside chat and one-on-one investor meetings. Tyra Biosciences focuses on developing next-generation precision medicines targeting opportunities in Fibroblast Growth Factor Receptor  biology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on August 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8WJx8w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2559964493","title":"Tyra Biosciences Q2 EPS $(0.47) Beats $(0.53) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559964493","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559964493?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:37","pubTimestamp":1755203836,"startTime":"0","endTime":"0","summary":"Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.53) by 11.15 percent. This is a 46.87 percent decrease over losses of $(0.32) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47140194/tyra-biosciences-q2-eps-0-47-beats-0-53-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Tyra Biosciences Q2 EPS $(0.47) Beats $(0.53) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA"],"gpt_icon":0},{"id":"2559964856","title":"Tyra Biosciences Inc - Co Has $296.3 Mln Cash, Runway Through 2027 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2559964856","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559964856?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:21","pubTimestamp":1755202873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nFWN3U60J9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2559964354","title":"Tyra Biosciences Q2 net loss widens to $28.1 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2559964354","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559964354?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:19","pubTimestamp":1755202779,"startTime":"0","endTime":"0","summary":"Tyra Biosciences Q2 net loss widens to $28.1 mlnOverviewTyra Biosciences Q2 net loss widens to $28.1 mln from $18.7 mln last yearBasic EPS beats analyst expectations, despite increased R&D and G&A exp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX3EE493:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2559904961","title":"Tyra Biosciences Q2 Basic EPS USD -0.47 VS. Ibes Estimate USD -0.53","url":"https://stock-news.laohu8.com/highlight/detail?id=2559904961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559904961?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201904,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX3EE493:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2559619099","title":"Tyra Biosciences Q2 Operating Expenses USD 31.452 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559619099","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559619099?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201904,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX3EE493:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2556684674","title":"Tyra Biosciences Inc  expected to post a loss of 53 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556684674","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556684674?lang=en_us&edition=fundamental","pubTime":"2025-08-02 05:29","pubTimestamp":1754083758,"startTime":"0","endTime":"0","summary":"Tyra Biosciences Inc  expected to post a loss of53cents a share - Earnings Preview Tyra Biosciences Inc TYRA.OQ TYRA.O is expected to  show no change in quarterly revenue when it reports  results on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL8N3TT30E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA"],"gpt_icon":0},{"id":"2553094204","title":"Tyra Biosciences to Participate in Virtual Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series","url":"https://stock-news.laohu8.com/highlight/detail?id=2553094204","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553094204?lang=en_us&edition=fundamental","pubTime":"2025-07-22 04:05","pubTimestamp":1753128336,"startTime":"0","endTime":"0","summary":"Tyra Biosciences to Participate in Virtual Fireside Chat on Achondroplasia and Growth Disorders at UBS Biotech Management Live Call Series. Tyra Biosciences Inc., a clinical-stage biotechnology company, will participate in a virtual fireside chat as part of the UBS Biotech Management Live Call Series on July 25, 2025. The event will focus on achondroplasia and growth disorders, with company management including CEO Todd Harris, CMO Doug Warner, MD, and CFO Alan Fuhrman participating.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via PR Newswire  on July 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDLnfnsc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2550578195","title":"Tyra Biosciences Announces Promising Preclinical Results for TYRA-300 in FGFR3-related Skeletal Dysplasia at ENDO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2550578195","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550578195?lang=en_us&edition=fundamental","pubTime":"2025-07-09 04:05","pubTimestamp":1752005140,"startTime":"0","endTime":"0","summary":"Tyra Biosciences Inc., a clinical-stage biotechnology company, has announced the upcoming presentation of preclinical results for their investigational drug, TYRA-300, at The Endocrine Society's Annual Meeting  in San Francisco, CA. The late-breaking poster presentation, titled \"TYRA-300 Promotes Bone Growth In Two Mouse Models Of FGFR3-related Skeletal Dysplasia,\" will be delivered by Dr. Jacqueline H. Starrett on July 13, 2025. This study focuses on the potential of TYRA-300 to address bone growth challenges associated with FGFR3-related skeletal dysplasia. The session will be part of the BONE AND MINERAL METABOLISM track, focusing on rare bone and genetic disorders. Further details and access to the poster will be available on Tyra Biosciences' website following the conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDL5GD83w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA","BK4139"],"gpt_icon":0},{"id":"2548063420","title":"Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2548063420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548063420?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:47","pubTimestamp":1751370420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TYRA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 01, 2025 07:47 ET (11:47 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA"],"gpt_icon":0},{"id":"2547560099","title":"Tyra Biosciences Initiates Phase 2 Trial of TYRA-300 for Bladder Cancer with First Patient Dosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2547560099","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547560099?lang=en_us&edition=fundamental","pubTime":"2025-06-30 20:01","pubTimestamp":1751284889,"startTime":"0","endTime":"0","summary":"Tyra Biosciences, Inc. has announced the commencement of dosing for the first patient in its Phase 2 SURF302 clinical trial, evaluating the efficacy and safety of TYRA-300 in patients with low-grade, intermediate risk non-muscle invasive bladder cancer . TYRA-300 is currently the only orally administered investigational agent in clinical development for this condition. The trial aims to enroll up to 90 participants across multiple sites in the United States. Participants will receive either 50 mg or 60 mg of TYRA-300 once daily. The study's primary endpoint is the complete response rate at three months, with initial data expected in the first half of 2026. Secondary endpoints include recurrence metrics and safety evaluations. Results from the trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL3mCdZ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TYRA"],"gpt_icon":0},{"id":"2545410392","title":"Director Gilla Kaplan Reports Disposal of Common Shares of Tyra Biosciences Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2545410392","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545410392?lang=en_us&edition=fundamental","pubTime":"2025-06-21 05:43","pubTimestamp":1750455817,"startTime":"0","endTime":"0","summary":"Gilla Kaplan, a Director at Tyra Biosciences Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tyra Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250620:nNDL6ysx5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Gilla Kaplan Reports Disposal of Common Shares of Tyra Biosciences Inc","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TYRA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}